An E2–F12 complex is required for intracellular enveloped virus morphogenesis during vaccinia infection

por Dodding, Mark P, Newsome, Timothy P, Collinson, Lucy M, Edwards, Ceri, Way, Michael
Publicado 2009

Phase 1 trial of recombinant Modified Vaccinia Ankara (MVA) encoding Epstein-Barr viral tumor antigens in nasopharyngeal carcinoma patients

por Hui, Edwin P, Taylor, Graham S, Jia, Hui, Ma, Brigette BY, Chan, Stephen L, Ho, Rosalie, Wong, WL, Wilson, Steven, Johnson, Benjamin F, Edwards, Ceri, Stocken, Deborah D, Rickinson, Alan B, Steven, Neil M, Chan, Anthony TC
Publicado en Cancer Res (2013)

A recombinant modified vaccinia Ankara vaccine encoding Epstein-Barr virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancer

por Taylor, Graham S., Jia, Hui, Harrington, Kevin, Lee, Lip Wai, Turner, James, Ladell, Kristin, Price, David A, Tanday, Manjit, Matthews, Jen, Roberts, Claudia, Edwards, Ceri, McGuigan, Lesley, Hartley, Andrew, Wilson, Steve, Hui, Edwin P., Chan, Anthony T. C., Rickinson, Alan B., Steven, Neil M.
Publicado en Clin Cancer Res (2014)

Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunological and Clinical Outcomes

por McCann, Katy J., Mander, Ann, Cazaly, Angelica, Chudley, Lindsey, Stasakova, Jana, Thirdborough, Stephen, King, Andrew, Lloyd-Evans, Paul, Buxton, Emily, Edwards, Ceri, Halford, Sarah, Bateman, Andrew, O’Callaghan, Ann, Clive, Sally, Anthoney, Alan, Jodrell, Duncan I., Weinschenk, Toni, Simon, Petra, Sahin, Ugur, Thomas, Gareth J., Stevenson, Freda K., Ottensmeier, Christian H.
Publicado en Clin Cancer Res (2016)